Importantly, R848@M2pep-MPsAFP-reprogrammed M2-like TAMs process and present AFP antigen to CD8+ T cells with R848 as the immune adjuvant, resulting in promoted CD8+ T cell proliferation and activation as well as enhanced stem-like CD8+ T cells in tumor tissues. This evidence concerns the gene CD8A and neoplasm.